Reduced aerobic capacity and physical functioning in older HIV-infected men

AIDS Research and Human Retroviruses

Volumn 22, Issue 11, 2006, Pages 1113-1121

  Oursler, Krisann K ^a,b   Sorkin, J D ^a,b   Smith, B A ^c   Katzel, L I ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AEROBIC CAPACITY; AGE; AGING; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PHYSICAL DISABILITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; TREADMILL EXERCISE; UNITED STATES; VETERAN; WALKING;

ADULT; AGED; AGING; EXERCISE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHYSICAL FITNESS;

EID: 33845420451     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.1113     Document Type: Article

References (61)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-860.
2. Ory MG, Zablotsky DL, and Crystal S: HIV/AIDS and aging: Identifying a prevention research and care agenda. Res Aging 1998;20(6):637-652.
3. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report, 2004. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention 2005;16:20, Table 10.
4. Levy JA, Holmes D, and Smith M: Conceptual and methodological issues in research on age and aging. J Acquir Immune Defic Syndr 2003;33(Suppl 2):S206-S217.
5. Stoff DM, Khalsa JH, Monjan A, and Portegies P: Introduction: HIV/AIDS and Aging. AIDS 2004;18(Suppl 1):S1-S2.
6. Wang L, van Belle G, Kukull WB, and Larson EB: Predictors of functional change: A longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc 2002;50(9):1525-1534.
7. Fried LP, Brandeen-Roche K, Kasper JD, and Guralnik JM: Association of comorbidity with disability in older women: The Women's Health and Aging Study. 1999;52(1):27-37.
8. Burke GL, Arnold AM, Bild DE, Cushman M, Fried LP, Newman A, et al.: Factors associated with healthy aging: The cardiovascular health study. J Am Geriatr Soc 2001;49(3):254-262.
9. Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, et al.: The 6-min walk test: A quick measure of functional status in elderly adults. Chest 2003;123(2):387-398.
10. Janssen I, Heymsfield SB, and Ross R: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50(5):889-896.
11. Stewart AL, Hays RD, Wells KB, Rogers WH, Spritzer KL, and Greenfield S: Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic condition in the Medical Outcomes Study. J Clin Epidemiol 1994;47(7):719-730.
12. Justice AC, Aiken LH, Smith HL, and Turner BJ: The role of functional status in predicting inpatient mortality with AIDS: A comparison with current predictors. J Clin Epidemiol 1996;49(2):193-201.
13. Fleishman JA and Crystal S: Functional status transitions and survival in HIV disease: Evidence from the AIDS Costs and Service Utilization Survey. Med Care 1998;36(4):533-543.
14. Stanton DL, Wu AW, Moore RD, Rucker SC, Piazza MP, Abrams JE, et al.: Functional status of persons with HIV infection in an ambulatory setting. J Acquir Immune Defic Syndr 1994;7(10):1050-1056.
15. O'Dell MW, Hubert HB, Lubeck DP, and O'Driscoll P: Physical disability in a cohort of persons with AIDS: Data from the AIDS Time-Oriented Health Outcome Study. AIDS 1996;10(6):667-673.
16. Crystal S and Samamoorthi U: Functional impairment trajectories among persons with HIV disease: A hierarchical linear models approach. Health Serv Res 1996;31(4):469-488.
17. Cade WT, Peralta L, and Keyser RE: Aerobic exercise dysfunction in human immunodeficiency virus: A potential link to physical disability. Eur J Appl Physiol 2004;84(7):655-664.
18. Stringer WW: Mechanisms of exercise limitation in HIV+ individuals. Med Sci Sports Exerc 2000;32(7 Suppl.):S412-S421.
19. Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, and Weissman S: General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol 2001;54(Suppl 1):S22-S28.
20. Crystal S, Fleishman JA, Hays RD, Shapiro MF, and Bozzette SA: Physical and role functioning among persons with HIV: Results from a nationally representative survey. Med Care 2000;38(12):1210-1223.
21. Rusch M, Nixon S, Schilder A, Braitstein P, Chan K, and Hogg RS: Impairments, activity limitations and participation restrictions: Prevalence and associations among persons living with HIV/AIDS in British Columbia. Health Qual Life Outcomes 2004;2(1):46.
22. Solway S, Brooks D, Lacasse Y, and Thomas S: A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119(1):256-270.
23. Grinspoon S, Corcoran C, Rosenthal D, Stanley T, Parlman K, Costello M, et al.: Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab 1999;84(1):201-206.
24. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, and Guralnik JM: Handgrip strength and cause-specific and total mortality in older disabled women: Exploring the mechanism. J Am Geriatr Soc 2003;51(5):636-641.
25. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, et al.: Midlife hand grip strength as a predictor of old age disability. JAMA 1999;281(6):558-560.
26. Cuerda C, Zugasti A, Breton I, Camblor M, Miralles P, and Garcia P: Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men. Nutr Clin Pract 2005;20(1):93-97.
27. Bassett DR, Howley ET: Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sport Exerc 2000;32:70-84.
28. Noakes TD: Implications of exercise testing for prediction of athletic performance: A contemporary perspective. Med Sci Sports Exerc 1988;20(4):319-330.
29. Taffet GE, Lakatta EG: Aging of the cardiovascular System. In: Principles of Geriatric Medicine and Gerontology (Hazzard WR, Blass JP, Halter JB, Ouslander JG, and Tinnetti ME, eds.). Mc-Graw-Hill, New York, 2003, pp. 403-422.
30. Rosen MJ, Sorkin JD, Goldberg AP, Hagberg JM, and Katzel LI: Predictors of age-associated decline in maximal aerobic capacity: A comparison of four statistical models. J Appl Phys 1998;84:2163-2170.
31. Katzel LI, Sorkin JD, and Fleg JL: A comparison of longitudinal changes in aerobic fitness in older endurance athletes and sedentary men. J Am Geriatr Soc 2001;49:1657-1664.
32. MacArthur RD, Levine SD, and Birk TJ: Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc 1993;25(6):684-688.
33. Pothoff G, Wassermann K, and Ostmann H: Impairment of exercise capacity in various groups of HIV-infected patients. Respiration 1994;61(2):80-85.
34. Johnson JE, Anders GT, Blanton HM, Hawkes CE, Bush BA, McAllister CK, et al.: Exercise dysfunction in patients seropositive for the human immunodeficiency virus. Am Rev Respir Dis 1990;141(3):618-622.
35. Keyser RE, Peralta L, Cade WT, Miller S, and Anixt J: Functional aerobic impairment in adolescents seropostive for HIV: a quasiexperimental design. Arch Phys Med Rehabil 2000;81:1479-1484.
36. Cade WT, Fantry LE, Nabar SR, Shaw DK, and Keyser RE: A comparison of Qt and a-vO2 in individuals with HIV taking and not taking HAART. Med Sci Sports Exerc 2003;35(7):1108-1117.
37. American College of Sports Medicine: ACSM's Guidelines for Exercise Testing and Prescription, 7th ed. Williams & Wilkins, Philadelphia, PA, 2006.
38. Snedecor G and Cochran W: Statistical Methods, 8th ed. Iowa State University Press, Ames, IA, 1989, pp. 187-190.
39. Enright PL and Sherrill DL: Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5 Pt 1):1384-1387.
40. Luna-Heredia E, Martin-Pena G, and Ruiz-Galiana J. Handgrip dynamometry in healthy adults. Clin Nutr 2005;24(2):250-258.
41. Gottlieb SS, Fisher ML, Freudenberger R, Robinson S, Zietowski G, Alves L, et al.: Effects of exercise training on peak performance and quality of life in congestive heart failure patients. J Card Fail 1999;5(3):188-194.
42. Gardner AW, Katzel LI, Sorkin JD, Bradham DD, Hochberg MC, Flinn WR, et al.: Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc 2001;49:755-762.
43. Macko RF, Katzel LI, Yataco A, Tretter L, Desouza CA, Dengel DR, et al.: Low velocity graded treadmill stress testing in hemiparetic stroke patients. Stroke 1997;28:988-992.
44. Social Security Administration. Disability Evaluation Under Social Security (Blue Book - January 2005). SSA Pub No. 64-039 2005.
45. Yunis NA and Stone VE: Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(2):145-154.
46. Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al.: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349(12):1993-2003.
47. Martinez-Sierra C, Arizcorreta A, Diaz F, Roldan R, Martin-Herrera L, Perez-Guzman E, et al.: Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2003;36(4):491-498.
48. Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, et al.: The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005;20(12):1142-1145.
49. Semba RD, Martin BK, Kempen JH, Thorne JE, and Wu AW: The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 2005;165(19):2229-2236.
50. Revicki DA, Brown RE, Henry DH, McNeill MV, Rios A, and Watson T: Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia. J Acquir Immune Defic Syndr 1994;7(5):474-484.
51. Lee H, Hanes J, and Johnson KA: Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 2003;42(50):14711-14719.
52. Lopez S, Negredo E, Garrabou G, Puig J, Ruiz L, Sanjurjo E, et al.: Longitudinal study on mitochondrial effects of didanosine-tenofovir combination. AIDS Res Hum Retroviruses 2006;22(1):33-39.
53. Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, and Koopmans PP: Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway. AIDS 1998;12(14):1735-1744.
54. Arnaudo E, Dalakas M, Shanske S, Moraes CT, DiMauro S, and Schon EA: Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991;337:508-510.
55. Chapplain JM, Beillot J, Begue JM, Souala F, Bouvier C, Arvieux C, et al.: Mitochondrial Abnormalities in HIV-Infected Lipoatrophic Patients Treated With Antiretroviral Agents. J Acquir Immune Defic Syndr 2004;37(4):1477-1488.
56. Haugaard SB, Andersen O, Pedersen SB, Dela F, Richelsen B, Nielsen JO, et al.: Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. J Med Virol 2005;77(1):29-38.
57. Miura T, Goto M, Hosoya N, Odawara T, Kitamura Y, Nakamura T, et al.: Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. J Med Virol 2003;70(4):497-505.
58. Miro O, Lopez S, Martinez E, Pedrol E, Milinkovic A, Deig E, et al.: Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin Infect Dis 2004;39(5):710-716.
59. Ship JA, Wolff A, and Selik RM: Epidemiology of acquired immune deficiency syndrome in persons age 50 years or older. J Acquir Immune Defic Syndr 1991;4(1):84-88.
60. Gordon SM and Thompson S: The changing epidemiology of human immunodeficiency virus infection in older persons. J Am Geriatr Soc 1995;43(1):7-9.
61. Guralnik JM, Branch LG, Cummings SR, and Curb JD: Physical performance measures in aging research. J Gerontol 1989;44(5):M141-M146.